JP2010132694A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010132694A5 JP2010132694A5 JP2010041778A JP2010041778A JP2010132694A5 JP 2010132694 A5 JP2010132694 A5 JP 2010132694A5 JP 2010041778 A JP2010041778 A JP 2010041778A JP 2010041778 A JP2010041778 A JP 2010041778A JP 2010132694 A5 JP2010132694 A5 JP 2010132694A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- oxcarbazepine
- oxacarbazepine
- sieve
- maximum residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- CTRLABGOLIVAIY-UHFFFAOYSA-N oxcarbazepine Chemical compound C1C(=O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 CTRLABGOLIVAIY-UHFFFAOYSA-N 0.000 claims 13
- 229960001816 oxcarbazepine Drugs 0.000 claims 13
- 238000009472 formulation Methods 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 239000002245 particle Substances 0.000 claims 7
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 206010010904 Convulsion Diseases 0.000 claims 1
- 229940126534 drug product Drugs 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 238000005469 granulation Methods 0.000 claims 1
- 230000003179 granulation Effects 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH33197 | 1997-02-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005346338A Division JP2006077029A (ja) | 1997-02-14 | 2005-11-30 | オキサカルバゼピンフィルム被覆錠剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010132694A JP2010132694A (ja) | 2010-06-17 |
| JP2010132694A5 true JP2010132694A5 (https=) | 2012-05-31 |
Family
ID=4184588
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10535347A Withdrawn JP2000511935A (ja) | 1997-02-14 | 1998-02-12 | オキサカルバゼピンフィルム被覆錠剤 |
| JP2005346338A Withdrawn JP2006077029A (ja) | 1997-02-14 | 2005-11-30 | オキサカルバゼピンフィルム被覆錠剤 |
| JP2010041778A Pending JP2010132694A (ja) | 1997-02-14 | 2010-02-26 | オキサカルバゼピンフィルム被覆錠剤 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10535347A Withdrawn JP2000511935A (ja) | 1997-02-14 | 1998-02-12 | オキサカルバゼピンフィルム被覆錠剤 |
| JP2005346338A Withdrawn JP2006077029A (ja) | 1997-02-14 | 2005-11-30 | オキサカルバゼピンフィルム被覆錠剤 |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US20070036863A1 (https=) |
| EP (1) | EP0966287B1 (https=) |
| JP (3) | JP2000511935A (https=) |
| KR (3) | KR19980071337A (https=) |
| CN (2) | CN1626093A (https=) |
| AR (1) | AR011142A1 (https=) |
| AT (1) | ATE239481T1 (https=) |
| AU (1) | AU738030B2 (https=) |
| BR (1) | BR9807368A (https=) |
| CA (1) | CA2277791C (https=) |
| CO (1) | CO4920215A1 (https=) |
| CY (1) | CY2480B1 (https=) |
| CZ (1) | CZ298840B6 (https=) |
| DE (1) | DE69814367T2 (https=) |
| DK (1) | DK0966287T3 (https=) |
| ES (1) | ES2199422T3 (https=) |
| HU (1) | HU227807B1 (https=) |
| ID (1) | ID22348A (https=) |
| MY (1) | MY117582A (https=) |
| NO (1) | NO327486B1 (https=) |
| NZ (1) | NZ336946A (https=) |
| PE (1) | PE58999A1 (https=) |
| PL (1) | PL193332B1 (https=) |
| PT (1) | PT966287E (https=) |
| RU (1) | RU2201218C2 (https=) |
| SK (1) | SK284503B6 (https=) |
| TR (1) | TR199901804T2 (https=) |
| TW (1) | TW529957B (https=) |
| UY (1) | UY24888A1 (https=) |
| WO (1) | WO1998035681A1 (https=) |
| ZA (1) | ZA981205B (https=) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
| GB9925962D0 (en) * | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
| US6368628B1 (en) * | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
| PL371259A1 (pl) | 2001-12-21 | 2005-06-13 | Pfizer Products Inc. | Bezpośrednio sprasowywalne preparaty azytromycyny |
| GB0221956D0 (en) * | 2002-09-20 | 2002-10-30 | Novartis Ag | Organic compounds |
| EP1663247B1 (en) | 2003-09-03 | 2009-10-28 | Novartis AG | Use of oxcarbazepine for the improvement of sleep in patients suffering from chronic pain |
| AR048318A1 (es) * | 2004-03-22 | 2006-04-19 | Novartis Ag | Formulaciones de matriz orales que comprenden licarbazepina |
| PE20060124A1 (es) * | 2004-03-22 | 2006-03-07 | Novartis Ag | Tabletas de desintegracion que comprenden licarbazepina |
| US8367105B2 (en) | 2004-11-10 | 2013-02-05 | Teva Pharmaceutical Industries, Ltd. | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby |
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| DE602006011485D1 (de) | 2005-09-23 | 2010-02-11 | Hoffmann La Roche | Neue dosierformulierung |
| CN102775396B (zh) | 2005-11-08 | 2014-10-08 | 沃泰克斯药物股份有限公司 | Atp-结合弹夹转运蛋白的杂环调控剂 |
| AU2006313009B2 (en) * | 2005-11-10 | 2013-10-24 | Alphapharm Pty Ltd | Process to control particle size |
| WO2007053904A1 (en) * | 2005-11-10 | 2007-05-18 | Alphapharm Pty Ltd | Process to control particle size |
| JP2008540346A (ja) * | 2006-01-31 | 2008-11-20 | テバ ファーマシューティカル インダストリーズ リミティド | オキシカルバゼピンの医薬製剤及びその調製方法 |
| EP1815849A1 (en) * | 2006-01-31 | 2007-08-08 | Teva Pharmaceutical Industries Ltd | Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| EP2010499A4 (en) * | 2006-04-21 | 2012-07-18 | Alphapharm Pty Ltd | PHARMACEUTICAL COMPOSITION OF OXCARBAZEPINE PARTICULATE FROM 15 TO 30 MICRONS IN AVERAGE |
| ES2360423T3 (es) * | 2006-04-26 | 2011-06-03 | Supernus Pharmaceuticals, Inc. | Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal. |
| EP2018157A2 (en) | 2006-04-26 | 2009-01-28 | Astron Research Limited | Controlled release formulation comprising anti-epileptic drugs |
| US20080138403A1 (en) * | 2006-12-08 | 2008-06-12 | Sun Pharmaceutical Industries Ltd. | Pharmaceutical dosage forms of oxcarbazepine |
| EP2476418A1 (en) | 2006-12-21 | 2012-07-18 | Alphapharm Pty Ltd. | Pharmaceutical compound and composition for use in treating type II diabetes comprising rosiglitazone in a specific particle size |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| EP1970056A1 (en) * | 2007-03-15 | 2008-09-17 | Polichem S.A. | Time-specific delayed/pulsatile release dosage forms |
| WO2008141751A2 (en) * | 2007-05-23 | 2008-11-27 | Ratiopharm Gmbh | Pharmaceutical compositions comprising oxcarbazepine |
| US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| EP3683218B1 (en) | 2007-12-07 | 2024-09-18 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| JP2013523833A (ja) | 2010-04-07 | 2013-06-17 | バーテックス ファーマシューティカルズ インコーポレイテッド | ３−（６−（１−（２，２−ジフルオロベンゾ［ｄ］［１，３］ジオキソール−５−イル）シクロプロパンカルボキサミド）−３−メチルピリジン−２−イル）安息香酸の医薬組成物およびその投与 |
| NZ727015A (en) | 2012-01-25 | 2017-12-22 | Vertex Pharma | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| AU2014349010C1 (en) | 2013-11-12 | 2020-08-06 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases |
| CN103735527B (zh) * | 2013-12-24 | 2014-09-10 | 武汉人福药业有限责任公司 | 一种奥卡西平片剂及其制备方法 |
| WO2018208242A1 (en) | 2017-05-10 | 2018-11-15 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Formulation of deferasirox tablet for oral suspension composition with better processability |
| TWI853027B (zh) | 2019-05-16 | 2024-08-21 | 瑞士商諾華公司 | N-[4-(氯二氟甲氧基)苯基]-6-[(3r)-3-羥基吡咯啶-1-基]-5-(1h-吡唑-5-基)吡啶-3-甲醯胺之結晶形狀 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI75561C (fi) * | 1979-10-30 | 1988-07-11 | Ciba Geigy Ag | Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter. |
| CH649080A5 (de) * | 1981-04-16 | 1985-04-30 | Ciba Geigy Ag | 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz. |
| US4609675A (en) * | 1984-08-17 | 1986-09-02 | The Upjohn Company | Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing |
| JPS6257467A (ja) * | 1985-09-06 | 1987-03-13 | Asahi Glass Co Ltd | コ−テイング剤組成物 |
| GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
| CH668187A5 (de) * | 1986-08-07 | 1988-12-15 | Ciba Geigy Ag | Therapeutisches system mit systemischer wirkung. |
| DD295760A5 (de) * | 1989-01-31 | 1991-11-14 | Martin-Luther-Universitaet Halle Wittenberg,De | Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
| FR2699077B1 (fr) * | 1992-12-16 | 1995-01-13 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. |
| FR2702148B1 (fr) * | 1993-03-05 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement du neuro-sida. |
| US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
| US5478654A (en) * | 1994-05-06 | 1995-12-26 | Gencorp Inc. | Solventless carboxylated butadiene-vinylidene chloride adhesives for bonding rubber to metal |
| US5980942A (en) * | 1997-01-23 | 1999-11-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release matrix tablet formulations of carbamazepine |
| US6296873B1 (en) * | 1997-01-23 | 2001-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release delivery system for carbamazephine derivatives |
| CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
-
1998
- 1998-02-05 CO CO98005805A patent/CO4920215A1/es unknown
- 1998-02-09 MY MYPI98000504A patent/MY117582A/en unknown
- 1998-02-11 PE PE1998000100A patent/PE58999A1/es not_active Application Discontinuation
- 1998-02-12 DE DE69814367T patent/DE69814367T2/de not_active Revoked
- 1998-02-12 RU RU99119599/14A patent/RU2201218C2/ru not_active IP Right Cessation
- 1998-02-12 CZ CZ0287999A patent/CZ298840B6/cs not_active IP Right Cessation
- 1998-02-12 DK DK98908091T patent/DK0966287T3/da active
- 1998-02-12 AU AU66222/98A patent/AU738030B2/en not_active Ceased
- 1998-02-12 WO PCT/EP1998/000794 patent/WO1998035681A1/en not_active Ceased
- 1998-02-12 NZ NZ336946A patent/NZ336946A/en not_active IP Right Cessation
- 1998-02-12 PT PT98908091T patent/PT966287E/pt unknown
- 1998-02-12 CN CNA200410075200XA patent/CN1626093A/zh active Pending
- 1998-02-12 AR ARP980100639A patent/AR011142A1/es not_active Application Discontinuation
- 1998-02-12 CA CA002277791A patent/CA2277791C/en not_active Expired - Fee Related
- 1998-02-12 EP EP98908091A patent/EP0966287B1/en not_active Revoked
- 1998-02-12 SK SK1098-99A patent/SK284503B6/sk not_active IP Right Cessation
- 1998-02-12 PL PL334959A patent/PL193332B1/pl unknown
- 1998-02-12 HU HU0000886A patent/HU227807B1/hu not_active IP Right Cessation
- 1998-02-12 CN CNB988024977A patent/CN1170542C/zh not_active Expired - Fee Related
- 1998-02-12 JP JP10535347A patent/JP2000511935A/ja not_active Withdrawn
- 1998-02-12 BR BR9807368-0A patent/BR9807368A/pt not_active Application Discontinuation
- 1998-02-12 ID IDW990810A patent/ID22348A/id unknown
- 1998-02-12 AT AT98908091T patent/ATE239481T1/de not_active IP Right Cessation
- 1998-02-12 TR TR1999/01804T patent/TR199901804T2/xx unknown
- 1998-02-12 ES ES98908091T patent/ES2199422T3/es not_active Expired - Lifetime
- 1998-02-13 UY UY24888A patent/UY24888A1/es not_active IP Right Cessation
- 1998-02-13 KR KR1019980004327A patent/KR19980071337A/ko not_active Ceased
- 1998-02-13 ZA ZA981205A patent/ZA981205B/xx unknown
- 1998-02-23 TW TW087102046A patent/TW529957B/zh not_active IP Right Cessation
-
1999
- 1999-08-13 NO NO19993919A patent/NO327486B1/no not_active IP Right Cessation
-
2004
- 2004-10-07 CY CY0400074A patent/CY2480B1/xx unknown
-
2005
- 2005-11-30 JP JP2005346338A patent/JP2006077029A/ja not_active Withdrawn
-
2006
- 2006-10-18 US US11/582,802 patent/US20070036863A1/en not_active Abandoned
-
2007
- 2007-07-17 US US11/879,329 patent/US20080014269A1/en not_active Abandoned
-
2009
- 2009-03-20 KR KR1020090024168A patent/KR20090037873A/ko not_active Ceased
-
2010
- 2010-02-26 JP JP2010041778A patent/JP2010132694A/ja active Pending
-
2012
- 2012-06-18 KR KR1020120065092A patent/KR20120079826A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010132694A5 (https=) | ||
| PH12015501782A1 (en) | Method for production of commercial nanoparticles and microparticle powders | |
| CN104288154B (zh) | 一种含有不同粒径范围的法匹拉韦药物组合物 | |
| SG10201805657PA (en) | Composite formulation for oral administration comprising ezetimibe and rosuvastatin | |
| JP2015501783A5 (https=) | ||
| JP2011063627A5 (https=) | ||
| IL192374A0 (en) | Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol | |
| NZ609840A (en) | Process for making multiparticulate gastroretentive dosage forms | |
| JP2013047831A5 (https=) | ||
| PH12015501780A1 (en) | Production of encapsulated nanoparticles at commercial scale | |
| WO2009108865A3 (en) | Tablets and preparation thereof | |
| JP2016539953A5 (https=) | ||
| WO2013132457A3 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
| WO2012053785A3 (ko) | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 | |
| WO2015003479A3 (zh) | 一种适用于婴幼儿及儿童的口服固体颗粒及其制备方法 | |
| MX350531B (es) | Granulados que comprenden acetato de eslicarbazepina. | |
| SA520411573B1 (ar) | تحضير صور جرعة صلبة تشتمل على أجسام مضادة بعمل طبقات من المحلول/ المعلق | |
| PL401676A1 (pl) | Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania | |
| RU2017118329A (ru) | Частицы кадотрила | |
| JP2015510935A5 (https=) | ||
| EA033291B1 (ru) | Единица дозирования, содержащая рамиприл и бисопролола гемифумарат, способ ее получения и способ лечения гипертензии | |
| CN106692095A (zh) | 一种布瓦西坦药物口服缓释制剂及其制备方法 | |
| WO2006097725A3 (en) | Pharmaceutical compositions comprising microparticles for delivery into neurons | |
| ZA200805793B (en) | Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol | |
| CN102895275A (zh) | 一种红参超微粉及其制备方法 |